HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

In Brief: Advanced Polymer/Avon agreement

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

Advanced Polymer/Avon agreement: Gives Avon exclusive worldwide licensing rights to Advanced Polymer's Microsponge technology for retinol in cosmetics products sold in direct-sales distribution, Advanced Polymer Systems announced Aug. 1. Avon will use the Microsponge-entrapped retinol "in cosmetic products designed to improve the appearance of fine lines and wrinkles," Advanced Polymer stated. Avon currently markets the retinol-containing products BioAdvance and BioAdvance 2000...

Advanced Polymer/Avon agreement: Gives Avon exclusive worldwide licensing rights to Advanced Polymer's Microsponge technology for retinol in cosmetics products sold in direct-sales distribution, Advanced Polymer Systems announced Aug. 1. Avon will use the Microsponge-entrapped retinol "in cosmetic products designed to improve the appearance of fine lines and wrinkles," Advanced Polymer stated. Avon currently markets the retinol-containing products BioAdvance and BioAdvance 2000....
Table

View full table

Tags:
Latest Headlines

California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits

Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer

‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation

Probiotics And Cold Remedies Boost Recordati In 2023

See All
UsernamePublicRestriction

Register

RS003055

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By